These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 26684534)
1. Sugammadex - time of onset: nine months. Dalton J; Van Hasselt G Anaesthesia; 2016 Jan; 71(1):115-6. PubMed ID: 26684534 [No Abstract] [Full Text] [Related]
2. Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex. Ploeger BA; Smeets J; Strougo A; Drenth HJ; Ruigt G; Houwing N; Danhof M Anesthesiology; 2009 Jan; 110(1):95-105. PubMed ID: 19104176 [TBL] [Abstract][Full Text] [Related]
3. Sugammadex--a short review and clinical recommendations for the cardiac anesthesiologist. Hemmerling TM; Zaouter C; Geldner G; Nauheimer D Ann Card Anaesth; 2010; 13(3):206-16. PubMed ID: 20826961 [TBL] [Abstract][Full Text] [Related]
4. In vivo animal studies with sugammadex. Booij LH; van Egmond J; Driessen JJ; de Boer HD Anaesthesia; 2009 Mar; 64 Suppl 1():38-44. PubMed ID: 19222430 [TBL] [Abstract][Full Text] [Related]
5. Effect of magnesium sulphate on sugammadex reversal time for neuromuscular blockade: a randomised controlled study. Germano Filho PA; Cavalcanti IL; Barrucand L; Verçosa N Anaesthesia; 2015 Aug; 70(8):956-61. PubMed ID: 25829048 [TBL] [Abstract][Full Text] [Related]
6. [Sugammadex--a new agent for reversal of neuromuscular blockade]. Claudius C; Gätke MR Ugeskr Laeger; 2009 Mar; 171(13):1091. PubMed ID: 19321086 [No Abstract] [Full Text] [Related]
8. Reversal of neuromuscular blockade by sugammadex after continuous infusion of rocuronium in patients randomized to sevoflurane or propofol maintenance anesthesia. Rex C; Wagner S; Spies C; Scholz J; Rietbergen H; Heeringa M; Wulf H Anesthesiology; 2009 Jul; 111(1):30-5. PubMed ID: 19512873 [TBL] [Abstract][Full Text] [Related]
9. Reversal of profound, high-dose rocuronium-induced neuromuscular blockade by sugammadex at two different time points: an international, multicenter, randomized, dose-finding, safety assessor-blinded, phase II trial. Pühringer FK; Rex C; Sielenkämper AW; Claudius C; Larsen PB; Prins ME; Eikermann M; Khuenl-Brady KS Anesthesiology; 2008 Aug; 109(2):188-97. PubMed ID: 18648227 [TBL] [Abstract][Full Text] [Related]
10. A train-of-four ratio of 0.9 may not certify adequate recovery after sugammadex. Suzuki T Acta Anaesthesiol Scand; 2011 Mar; 55(3):368-9. PubMed ID: 21288221 [No Abstract] [Full Text] [Related]
11. Emergency use of sugammadex after failure of standard reversal drugs. Lenz A; Hill G; White PF Anesth Analg; 2007 Mar; 104(3):585-6. PubMed ID: 17312213 [TBL] [Abstract][Full Text] [Related]
12. Reversal of rocuronium-induced neuromuscular blockade with sugammadex in pediatric and adult surgical patients. Plaud B; Meretoja O; Hofmockel R; Raft J; Stoddart PA; van Kuijk JH; Hermens Y; Mirakhur RK Anesthesiology; 2009 Feb; 110(2):284-94. PubMed ID: 19194156 [TBL] [Abstract][Full Text] [Related]
13. Sugammadex: a novel approach to reversal of neuromuscular blockade. Aniskevich S; Leone BJ; Brull SJ Expert Rev Neurother; 2011 Feb; 11(2):185-98. PubMed ID: 21306205 [TBL] [Abstract][Full Text] [Related]
14. Sugammadex: another milestone in clinical neuromuscular pharmacology. Naguib M Anesth Analg; 2007 Mar; 104(3):575-81. PubMed ID: 17312211 [TBL] [Abstract][Full Text] [Related]